Literature DB >> 12220740

Hormone trajectories leading to human birth.

Roger Smith1, Sam Mesiano, Shaun McGrath.   

Abstract

The mechanisms regulating human parturition and labor remain unknown. This ignorance is expensive as preterm birth is responsible for 70% of neonatal mortality and 50% of cerebral palsy. Methods for the prediction of preterm birth and treatments for women in preterm labor have poor efficacy reflecting our limited knowledge of the mechanisms involved. Recent research has supported the view that parturition is a cascade of events that commences early in pregnancy and involves the mother, fetus, placenta, membranes, cervix and myometrium. Although a number of the key hormones and proteins involved have been identified, the relationships between these factors in time and tissues remain unclear. Placental production of Corticotropin-releasing hormone (CRH) is proposed as an early event regulating the cascade of events. Central to the onset of parturition will be a mechanism for progesterone withdrawal and estrogen activation in human. Two forms of progesterone receptor with opposing actions exist in the human myometrium. Progesterone receptor A (PR-A) is a dominant negative repressor of progesterone receptor B (PR-B). Preliminary studies strongly support the hypothesis that the onset of human parturition is initiated by rising concentrations of PR-A in the myometrium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220740     DOI: 10.1016/s0167-0115(02)00105-2

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  46 in total

1.  Neonatal DNA methylation patterns associate with gestational age.

Authors:  James W Schroeder; Karen N Conneely; Joseph C Cubells; Varun Kilaru; D Jeffrey Newport; Bettina T Knight; Zachary N Stowe; Patricia A Brennan; Julia Krushkal; Frances A Tylavsky; Robert N Taylor; Ronald M Adkins; Alicia K Smith
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

2.  Unique suppression of prostaglandin H synthase-2 expression by inhibition of histone deacetylation, specifically in human amnion but not adjacent choriodecidua.

Authors:  Murray D Mitchell
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

3.  Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?

Authors:  Danielle A Swales; Leah A Grande; Deborah A Wing; Michelle Edelmann; Laura M Glynn; Curt Sandman; Roger Smith; Maria Bowman; Elysia Poggi Davis
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

Review 4.  Fetal exposure to placental corticotropin-releasing hormone (pCRH) programs developmental trajectories.

Authors:  Curt A Sandman
Journal:  Peptides       Date:  2015-04-01       Impact factor: 3.750

5.  Quantitative Proteomics by SWATH-MS of Maternal Plasma Exosomes Determine Pathways Associated With Term and Preterm Birth.

Authors:  Ramkumar Menon; Christopher Luke Dixon; Samantha Sheller-Miller; Stephen J Fortunato; George R Saade; Carlos Palma; Andrew Lai; Dominic Guanzon; Carlos Salomon
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

6.  Preterm birth without progesterone withdrawal in 15-hydroxyprostaglandin dehydrogenase hypomorphic mice.

Authors:  Jeffrey D Roizen; Minoru Asada; Min Tong; Hsin-Hsiung Tai; Louis J Muglia
Journal:  Mol Endocrinol       Date:  2007-09-13

7.  Global report on preterm birth and stillbirth (2 of 7): discovery science.

Authors:  Michael G Gravett; Craig E Rubens; Toni M Nunes
Journal:  BMC Pregnancy Childbirth       Date:  2010-02-23       Impact factor: 3.007

8.  The role of progesterone in prevention of preterm birth.

Authors:  Jodie M Dodd; Caroline A Crowther
Journal:  Int J Womens Health       Date:  2010-08-09

9.  Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial.

Authors:  Jodie M Dodd; Caroline A Crowther; Andrew J McPhee; Vicki Flenady; Jeffrey S Robinson
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-24       Impact factor: 3.007

10.  Prostaglandin treatment is associated with a withdrawal of progesterone and androgen at the receptor level in the uterine cervix.

Authors:  Ylva Vladic-Stjernholm; Tomislav Vladic; Chellakkan S Blesson; Gunvor Ekman-Ordeberg; Lena Sahlin
Journal:  Reprod Biol Endocrinol       Date:  2009-10-23       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.